Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Mar 2008):

Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

Full Abstract

Data on the efficacy of quetiapine in borderline personality disorder (BPD) are still scarce. We aimed to investigate the efficacy of quetiapine for impulsivity and a broad range of affective symptoms in BPD. In this 12-week open-label study, we included individuals with BPD who presented to psychiatric in- and outpatient services. After a gradual titration of quetiapine, a flexible dose (range, 100-800 mg) was administered. The main outcome measures consisted of the scores on patient-rated questionnaires (Barratt Impulsiveness Scale, Buss-Durkee Hostility Inventory, Affective Lability Scale, Spielberger State and Trait Anxiety Inventory, Spielberger State and Trait Anger Inventory, and Beck Depression Inventory) and on neurocognitive tasks related to impulsivity (Stroop Color Word Task and IOWA Gambling Task). A mixed linear model, correcting for age, sex, antidepressant use, and weeks in psychotherapy, was applied. Forty-one patients (34 females and 7 males; mean [SD] age, 27.0 [9.0] years) were enrolled in the study, 32 of which completed the trial. Patients' scores decreased significantly (mean [SD] difference; P value) on the Barratt Impulsiveness Scale (19.7 [2.0]; P < 0.0001), Buss-Durkee Hostility Inventory (11.5 [1.4]; P < 0.0001), Affective Lability Scale (0.75 [0.08]; P < 0.0001), Beck Depression Inventory (25.0 [1.7]; P < 0.0001), Spielberger State and Trait Anxiety Inventory state (19.9 [1.9]; P < 0.0001) and trait (20.8 [1.7]; P < 0.0001) subscale, and Spielberger State and Trait Anger Inventory state (7.3 [1.1]; P < 0.0001) and trait (10.1 [1.0]; P < 0.0001) subscale. In addition, patients showed significantly less inference on the Stroop Color Word Task and had more 'good choices' on the IOWA Gambling Task. These results suggest that quetiapine may be efficacious in the treatment of impulsivity and affective symptoms in BPD.

 

Author information

Author/s: Van den Eynde, Frédérique (F); Senturk, Vesile (V); Naudts, Kris (K); Vogels, Caroline (C); Bernagie, Katrien (K); Thas, Olivier (O); van Heeringen, Cornelis (C); Audenaert, Kurt (K);

Affiliation: Department of Psychiatry and Medical Psychology, Ghent University, Ghent, Belgium. Frederique.VandenEynde(-atsign-)iop.kcl.ac.uk

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal: Journal of clinical psychopharmacology (J Clin Psychopharmacol), published in United States. (Language: eng)

Reference: 2008-Apr; vol 28 (issue 2) : pp 147-55

Dates: Created 2008/03/17; Completed 2008/05/27;

PMID: 18344724, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antipsychotic Agents (0) ; Dibenzothiazepines (0) ; Receptors, Dopamine D2 (0) ; quetiapine (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

11/29/1982
7/30/2008
Higher Relevance Score (22)
Lower Relevance Score (9)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index